Pradeep Bhadauria
Chief Tech/Sci/R&D Officer at CIPLA LIMITED
Pradeep Bhadauria active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CIPLA LIMITED | Chief Tech/Sci/R&D Officer | 2019-12-31 | - |
| President | 2019-12-31 | - |
Career history of Pradeep Bhadauria
Former positions of Pradeep Bhadauria
| Companies | Position | Start | End |
|---|---|---|---|
Amneal Intermediate, Inc.
 Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Chief Tech/Sci/R&D Officer | 2019-04-01 | - |
Training of Pradeep Bhadauria
| Shri Govindram Seksaria Institute of Technology & Science | Undergraduate Degree |
| Birla Institute of Technology & Science | Graduate Degree |
Statistics
International
| India | 4 |
| United States | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
| President | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CIPLA LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Health Technology |
- Stock Market
- Insiders
- Pradeep Bhadauria
- Experience
